Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) traded down 0.8% during mid-day trading on Monday . The company traded as low as $1.20 and last traded at $1.20. Approximately 13,007 shares traded hands during trading, an increase of 375% from the average daily volume of 2,736 shares. The stock had previously closed at $1.21.
Ascletis Pharma Stock Down 0.8%
The business has a fifty day moving average price of $1.30 and a two-hundred day moving average price of $1.63.
About Ascletis Pharma
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
See Also
- Five stocks we like better than Ascletis Pharma
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
